UK perspective: Harnessing the power of global collaboration in Precision Oncology
Disclaimer:The views expressed in this article reflect the professional perspective and experience of Excellence First Enterprise Consultancy Ltd (EFEC). This content is intended for informational purposes only and does not constitute commercial endorsement, medical advice, or solicitation of investment. EFEC is committed to providing balanced, objective commentary and supports open,…
Cambridge Innovation Capital commits £100m to back University of Cambridge spinouts
New Entrepreneur in Residence programme matches serial entrepreneurs with academics to develop world-leading ideas and IP.
Revenue growth continues - H1 and Q2 2025 results
Pascal Soriot, Chief Executive Officer, AstraZeneca, commenting on the results said:“Our strong momentum in revenue growth continued through the first half of the year and the delivery from our broad and diverse pipeline has been excellent, with 12 positive key Phase III trial readouts including for baxdrostat, gefurulimab, and Tagrisso in just the past few weeks.
Preventing patient hospitalisation through better stratification and timely intervention
In the realm of healthcare, patient hospitalisation can often be avoided through timely intervention and appropriate medication management.
Centauri Therapeutics receives an additional $5.1M from CARB-X to progress ABX-01 lead compound to first in human clinical trials
CARB-X provides an additional $5.1M to complete the non-clinical safety and efficacy studies with ABX-01 lead candidateCentauri plans the progression of lead candidate, an immunotherapy based broad-spectrum antimicrobial, to a first in human clinical study in early 2026
Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease
EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular oedemaPhase IIb trial to investigate efficacy in NPDR patients to commence in Q1 2026
Unlock the power of lead nurturing for business growth
Nurturing leads and customers isn’t just about courtesy- it’s a powerful way to boost engagement, conversions, and long-term value for your business, with some companies seeing 30%+ conversion rates from nurtured leads turned into customers.
Navigating the UK life sciences talent landscape in 2025: Growth opportunities, key challenges and strategies for integrating Chinese expertise
Disclaimer: This article is intended for industry professionals and provides general educational information only. It does not promote specific products or constitute medical advice.Market OverviewThe UK life sciences sector remains a cornerstone of the national economy, employing around 300,000 people and contributing approximately £100 billion annually. In 2025, the market shows signs of…
PhoreMost appoints Dr Adam Gilbert to Scientific Advisory Board
Expert in targeted protein degradation and drug discovery will support development of the Company’s portfolio of novel small molecule degraders
A cancer survivor who underwent complex ‘very major surgery’ has praised the robotic surgery that removed all traces of the disease from her body
Cancer survivor Stephanie Hemming, from Cambridge, underwent complex, major surgery in January - with a surgeon performing robotic surgery on her following her diagnosis of pancreatic cancer. Here, she talks about her diagnosis, her praise for both the surgeon who performed the surgery as well as the robotic surgery itself, and how lucky she feels to be living in Cambridge - to receive some of…
Top robotic surgeons at Addenbrooke’s say robots unlikely to ever fully replace them in theatre – but say they could ‘co-pilot’
Researchers from Johns Hopkins University in the US have reported that a robot had performed realistic surgery on its own with 100% accuracy. Having trained on videos of surgeries, the robot was able to remove a gallbladder from a life-like patient, performing a total of 17 tasks within the surgery, performing with the expertise of a skilled human surgeon, even during unexpected scenarios…
From complexity to clarity: analytics in cell and gene therapy
Cell and gene therapies (CGTs) have redefined the treatment landscape, but their development and manufacturing remain uniquely challenging. They involve variable starting materials and complex, small-scale processes. As the field pushes for faster development, scalable manufacturing and greater cost-efficiency—without compromising quality or safety—there is a clear shift toward automated, closed…
Faster, more accessible clinical trial initiative being piloted in pancreatic cancer
A pancreatic cancer trial led from Addenbrooke’s Hospital, Cambridge, is piloting a new scheme intended to make clinical trials faster and more accessible for patients in line with the NHS 10-year plan.
Milner Therapeutics Institute featured in AstraZeneca-University of Cambridge partnership impact report
The Milner Therapeutics Institute is delighted to be featured in a new report celebrating a decade of partnership and impact between AstraZeneca and the University of Cambridge
PhoreMost demonstrates new approach to rationalise molecular glue drug discovery
Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space
Shut up & listen: The real superpower you're probably ignoring
Let’s be honest - how often are you really listening in a conversation? Not nodding while you secretly plan what to say next. Not checking your phone while someone’s baring their soul. I mean actually tuning in like you're bingeing your favourite Netflix drama. That, my friends, is active listening—and it's a skill that can seriously change your life, both at work and at home.
RAEN & Shine
Authenticity is key for the latest brand to join Taank's stable. RAEN’s designers live and breathe ocean adventures and have a deep respect for nature. They share this reverence through their beautiful 'modern classic' frames that emit the warmth and energy of SoCal while remaining rooted in craftmanship and sustainability.
The world’s most precise eye test: Rodenstock DNEye® Scanner
Taank is the proud new owner of Rodenstock’s high-precision DNEye® Scanner, which will be used during every eye exam. This revolutionary scanner is the first of its kind to map each eye with absolute precision. Find out more about what it does and why we love it.
25 years of Guardtech: Isopod Manufacturing Director Michael Burton Q&A
One of the Group’s longest-serving superstars gives his thoughts on why the Guardtech Group are pushing the boundaries of small-scale cleanroom provision with their rapid-assembly pod systems
Music therapy may reduce distress for people with dementia
Research with CPFT finds that a new treatment approach using music therapy on NHS dementia wards could improve care and support for some of the most vulnerable NHS patients.
What does a fractional CMO do?
A fractional CMO provides high-level marketing strategy, leadership, and accountability on a part-time basis. This is ideal for businesses that need senior expertise without a full-time hire. Whether you're a startup or SME that’s scaling up, launching a product, fixing underperforming marketing, or filling a temporary gap, a fractional CMO offers results-driven direction and growth. From…
Danielle Lambe joins Salus Wellness
The team at Salus are pleased to announce that Danielle Lambe has joined Salus Wellness this month.
Yourgene Health launches LightBench Discover
Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing
Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
Cambridge, UK – 15 July 2025 – Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, today announced the first results from a collaboration with Insilico Medicine (“Insilico”), a clinic
Source Genomics X Cambridge Clinical Laboratories launch event
The Source Genomics X Cambridge Clinical Laboratories launch event took place at Endeavour House in Cambridge, bringing together colleagues and partners for an afternoon of expert presentations, laboratory tours, and networking. The event marked the official launch of Source Genomics’ acquisition of Cambridge Clinical Laboratories, highlighting a shared commitment to advancing clinical…